[go: up one dir, main page]

TR200002894T2 - L-Karnitin veya bir alkanoil L-Karnitin ve NADH ve/veya NADPH içeren kompozisyon - Google Patents

L-Karnitin veya bir alkanoil L-Karnitin ve NADH ve/veya NADPH içeren kompozisyon

Info

Publication number
TR200002894T2
TR200002894T2 TR2000/02894T TR200002894T TR200002894T2 TR 200002894 T2 TR200002894 T2 TR 200002894T2 TR 2000/02894 T TR2000/02894 T TR 2000/02894T TR 200002894 T TR200002894 T TR 200002894T TR 200002894 T2 TR200002894 T2 TR 200002894T2
Authority
TR
Turkey
Prior art keywords
carnitine
nadph
alkanoyl
composition containing
containing nadh
Prior art date
Application number
TR2000/02894T
Other languages
English (en)
Inventor
Cavazza Claudio
Original Assignee
Sigma-Tau Healhscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healhscience S.P.A. filed Critical Sigma-Tau Healhscience S.P.A.
Publication of TR200002894T2 publication Critical patent/TR200002894T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L-karnitin veya bir alkanoil L-karnitin veya bunlarin farmasötik olarak kabul edilebilir tuzu ve NADH ve/veya NADPH içeren, kronik yorgunluk sendromu ve Parkinson hastaliginin tedavisi için bir ilaç olarak ve yorucu fiziksel egzersizde bulunan kisiler veya kuvvetsiz denekler için bir diyet yardimcisi olarak yararli bir kompozisyon açiklanmaktadir.
TR2000/02894T 1998-04-17 1999-04-14 L-Karnitin veya bir alkanoil L-Karnitin ve NADH ve/veya NADPH içeren kompozisyon TR200002894T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98RM000238A IT1299161B1 (it) 1998-04-17 1998-04-17 Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph

Publications (1)

Publication Number Publication Date
TR200002894T2 true TR200002894T2 (tr) 2001-01-22

Family

ID=11405812

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02894T TR200002894T2 (tr) 1998-04-17 1999-04-14 L-Karnitin veya bir alkanoil L-Karnitin ve NADH ve/veya NADPH içeren kompozisyon

Country Status (17)

Country Link
EP (1) EP1071424A1 (tr)
JP (1) JP2002512191A (tr)
KR (1) KR20010042765A (tr)
CN (1) CN1299283A (tr)
AU (1) AU750645B2 (tr)
BR (1) BR9909712A (tr)
CA (1) CA2328331A1 (tr)
EE (1) EE200000601A (tr)
HU (1) HUP0101914A3 (tr)
IL (1) IL139014A0 (tr)
IS (1) IS5663A (tr)
IT (1) IT1299161B1 (tr)
NO (1) NO20005128L (tr)
PL (1) PL343482A1 (tr)
SK (1) SK15442000A3 (tr)
TR (1) TR200002894T2 (tr)
WO (1) WO1999053921A1 (tr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252309B2 (en) 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
DE10326822A1 (de) * 2003-06-11 2005-01-05 Herzpharma Vita-Check Diagnosegeräte GmbH Mittel zur Nahrungsergänzung, dieses Mittel enthaltende pharmazeutische Präparate und Verwendungen des Mittels
CA2686905C (en) * 2007-05-11 2015-07-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Gel useful for the delivery of cosmetic active ingredients
WO2011022786A1 (en) * 2009-08-31 2011-03-03 Pharmaqest Pty Ltd Methods for diagnosis and treatment of chronic fatigue syndrome
CN104306390A (zh) * 2014-10-23 2015-01-28 苏州人本药业有限公司 还原型辅酶ⅱ的用途
CN104840479A (zh) * 2015-02-17 2015-08-19 苏州人本药业有限公司 Nadph在制备治疗心脏疾病药物中的应用
US10894059B2 (en) 2017-12-22 2021-01-19 Bontac Bio-Engineering (Shenzhen) Co., Ltd NADH compound composition, and preparation and use thereof
EP3755160B1 (de) 2018-04-20 2021-11-03 Pacotrade AG Vorrichtung zum zerkleinern von in blockform bereitgestellten tiefgefrorenen lebensmitteln
CN109105702A (zh) * 2018-08-30 2019-01-01 泓博元生命科技（深圳）有限公司 一种含有nadh的组合物、应用及能量补充剂的制备方法
CN109170907A (zh) * 2018-08-30 2019-01-11 泓博元生命科技（深圳）有限公司 一种含有nmn的组合物、应用及运动饮料的制备方法
WO2020073922A1 (zh) * 2018-10-10 2020-04-16 梁苏娥 补虚损保健品组合物及其制备方法和其应用
CN117958433A (zh) * 2024-03-22 2024-05-03 四川新渔新美健康科技有限公司 不含咖啡因的抗疲劳功能组合物、饮料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054698A (tr) * 1964-12-04
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
JPH09110708A (ja) * 1995-08-11 1997-04-28 Taisho Pharmaceut Co Ltd 滋養強壮用生薬配合製剤
JPH0959161A (ja) * 1995-08-23 1997-03-04 Taisho Pharmaceut Co Ltd 疲労改善用組成物
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
JPH10175856A (ja) * 1996-10-14 1998-06-30 Taisho Pharmaceut Co Ltd 疲労改善剤

Also Published As

Publication number Publication date
EE200000601A (et) 2002-04-15
IS5663A (is) 2000-10-13
WO1999053921A1 (en) 1999-10-28
PL343482A1 (en) 2001-08-27
HUP0101914A3 (en) 2002-12-28
HUP0101914A2 (hu) 2002-03-28
SK15442000A3 (sk) 2001-06-11
CN1299283A (zh) 2001-06-13
NO20005128D0 (no) 2000-10-12
JP2002512191A (ja) 2002-04-23
IT1299161B1 (it) 2000-02-29
IL139014A0 (en) 2001-11-25
AU750645B2 (en) 2002-07-25
NO20005128L (no) 2000-12-18
CA2328331A1 (en) 1999-10-28
EP1071424A1 (en) 2001-01-31
ITRM980238A0 (it) 1998-04-17
KR20010042765A (ko) 2001-05-25
BR9909712A (pt) 2000-12-26
ITRM980238A1 (it) 1999-10-17
AU3442899A (en) 1999-11-08

Similar Documents

Publication Publication Date Title
TR200002894T2 (tr) L-Karnitin veya bir alkanoil L-Karnitin ve NADH ve/veya NADPH içeren kompozisyon
BR9714427A (pt) Aparelho e método para medir não invasivamente a produção cardìaca
WO2003013549A3 (de) Formulierung enthaltend (lyso-) phosphatidylserin zur vorbeugung und behandlung von stresszuständen bei warmblütern
BR9710585A (pt) Composição para administração enteral, processo para melhorar a resistência fìsica ou desempenho atlético de um mamìfero, para aumentar a concentração de proteìna, massa corporal sem gordura ou massa muscular em um mamìfero, para diminuir a deposição de gordura corporal para uma dada ingestão calórica e aumentar a perda de gordura corporal em um mamìfero, para tratar os efeitos catabólicos de doença em um mamìfero, para aperfeiçoar a resistência fìsica ou o desempenho atléticode um mamìfero, e, para aumentar a massa de um corpo de carne magra de um mamìfero e diminuir a deposição de gordura
CY1108629T1 (el) Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου
IL108284A0 (en) Use of riluzole for the treatment of parkinson's disease and parkinsonian syndromes
PT1163904E (pt) Composicao para a prevencao de doencas do musculo liso, compreendendo ascorbato, arginina e magnesio
MX9402938A (es) Composicion terapeutica que comprende nicotinamida-adenina-dinucleotido ynicotinamida-adenina-fosfato-dinucleotido, estable ingerible y absorbible.
PE20001325A1 (es) Combinacion de cerivastatina y fibratos
CA2377128A1 (en) Composition for the prevention of muscle fatigue and skeletal muscle adaptation to strenuous exercise
ATE366106T1 (de) Zusammensetzung für die pharmazeutische oder dietätische verwendung zur bekämpfung von haarausfall
CA2412789A1 (en) Compositions for improving mental concentration
HUP9700806A2 (hu) Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására
IT1295408B1 (it) Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
GR900300043T1 (en) Use of the enzyme-cofactor nadph in the preparation of a pharmaceutical, pharmaceutical and preparation thereof
EP1393738A4 (en) MEDICINE AGAINST DIABETES
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
BR9813856A (pt) Processos para o tratamento de uma paciente que sofre de sìndrome pré-menstrual, depressão, anemia, enxaquecas ou distúrbios alimentares e para aumentar o nìvel de serotonin em um ser humano com nìvel reduzido do mesmo no fluxo sanguìneo e composição
ES1052893U (es) Instrumento de gimnasia de balanceo.
Heikkinen et al. Growing Older-Staying Well: Ageing and physical activity in everyday life
WO1997005864A3 (en) Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
JPH11304793A5 (tr)
CN2836786Y (zh) 足底指压板
HUP9701606A2 (hu) Szulbutiamin alkalmazása bizonyos pszichomotoros és pszichointellektuális rendellenességek kezelésére használható gyógyszerkészítmények előállítására
BR0303384A (pt) Citalopram e seus usos no tratamento de pressão sanguìnea elevada